MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-30-2026
Merit Medical Systems Gross Profit 2011-2026 | MMSI
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Merit Medical Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 738 M | 643 M | 584 M | 519 M | 485 M | 401 M | 432 M | 395 M | 326 M | 265 M | 236 M | 225 M | 194 M | 182 M | 165 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 738 M | 165 M | 386 M |
Quarterly Gross Profit Merit Medical Systems
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 185 M | - | 184 M | 172 M | - | 158 M | 161 M | 152 M | - | 142 M | 153 M | 138 M | - | 129 M | 135 M | 121 M | - | 120 M | 124 M | 112 M | 111 M | 102 M | 84.2 M | 104 M | 112 M | 104 M | 112 M | 105 M | 105 M | 102 M | 100 M | 88.1 M | 85.7 M | 80.5 M | 84.1 M | 75.9 M | 70.3 M | 67.8 M | 66.9 M | 60.1 M | 60.3 M | 59.2 M | 60.9 M | 55.4 M | 60.1 M | 57.4 M | 55.6 M | 52 M | 53.4 M | 51 M | 47 M | 43 M | 45.5 M | 45.3 M | 47 M | 44.2 M | 42.1 M | 41.1 M | 42.5 M | 39.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 185 M | 39.8 M | 91.1 M |
Gross Profit of other stocks in the Medical instruments industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
62.4 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
2.68 B | $ 67.34 | 8.58 % | $ 13.4 B | USA |
 |
Glaukos Corporation
GKOS
|
283 M | $ 125.0 | 2.72 % | $ 7.15 B | USA |
 |
Luminex Corporation
LMNX
|
248 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
479 K | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
6.64 B | $ 422.06 | 0.77 % | $ 151 B | USA |
 |
Alcon
ALC
|
5.74 B | $ 66.81 | 0.35 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
822 M | $ 136.61 | 1.25 % | $ 3.37 B | USA |
 |
iRhythm Technologies
IRTC
|
527 M | $ 108.11 | 0.7 % | $ 3.46 B | USA |
 |
Repro Med Systems
KRMD
|
25.6 M | $ 3.93 | -5.07 % | $ 182 M | USA |
 |
LeMaitre Vascular
LMAT
|
179 M | $ 94.48 | 0.98 % | $ 2.14 B | USA |
 |
Masimo Corporation
MASI
|
1 B | $ 178.82 | -0.04 % | $ 9.53 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
86.5 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
436 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
1.68 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.48 B | - | -0.05 % | $ 10.3 B | USA |
 |
Microbot Medical
MBOT
|
117 K | $ 1.84 | -6.12 % | $ 84.3 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
6.84 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
6.41 M | $ 0.42 | -4.31 % | $ 34.5 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.38 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
27.8 M | $ 8.72 | -12.27 % | $ 74 K | USA |
 |
Envista Holdings Corporation
NVST
|
1.49 B | $ 23.1 | 1.03 % | $ 3.88 B | USA |
 |
Haemonetics Corporation
HAE
|
788 M | $ 71.28 | 2.05 % | $ 3.36 B | USA |
 |
STERIS plc
STE
|
2.63 B | $ 212.35 | 0.05 % | $ 20.9 B | USA |
 |
Isoray
ISR
|
1.43 M | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
182 M | $ 29.99 | 0.44 % | $ 1.49 B | USA |
 |
InfuSystem Holdings
INFU
|
80.3 M | $ 9.24 | 1.32 % | $ 191 M | USA |
 |
Teleflex Incorporated
TFX
|
307 M | $ 129.84 | -1.72 % | $ 5.79 B | USA |
 |
Utah Medical Products
UTMD
|
5.26 M | $ 67.65 | -0.5 % | $ 219 M | USA |
 |
West Pharmaceutical Services
WST
|
1.1 B | $ 314.5 | -0.89 % | $ 22.7 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.84 B | $ 10.0 | 1.21 % | $ 1.99 B | USA |
 |
Retractable Technologies
RVP
|
47 K | $ 0.69 | 3.96 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
19.5 M | $ 65.21 | -2.67 % | $ 214 M | USA |
 |
Predictive Oncology
POAI
|
6.53 K | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
62.1 M | $ 26.64 | -1.66 % | $ 1.27 B | USA |
 |
Stereotaxis
STXS
|
17.1 M | $ 1.78 | -5.07 % | $ 162 M | USA |
 |
Baxter International
BAX
|
3.38 B | $ 19.38 | 0.16 % | $ 9.94 B | USA |
 |
ResMed
RMD
|
2.02 B | $ 196.04 | 0.89 % | $ 28.6 B | USA |
 |
AtriCure
ATRC
|
401 M | $ 27.1 | -0.62 % | $ 1.29 B | USA |
 |
Harvard Bioscience
HBIO
|
49.9 M | $ 6.2 | -4.4 % | $ 275 M | USA |
 |
NeuroMetrix
NURO
|
1.68 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
158 M | $ 11.94 | -0.75 % | $ 488 M | USA |
 |
Becton, Dickinson and Company
BDX
|
8.29 B | $ 151.16 | 1.12 % | $ 43.5 B | USA |
 |
Nephros
NEPH
|
11.6 M | $ 3.42 | -4.74 % | $ 36.3 M | USA |
 |
OraSure Technologies
OSUR
|
48.2 M | $ 4.04 | -3.12 % | $ 297 M | USA |
 |
Repligen Corporation
RGEN
|
151 M | $ 122.31 | -3.35 % | $ 6.88 M | USA |